For patients not prescribed GLP-1 receptor agonists at 6-month follow-up, despite eConsult recommendations, the reasons for not prescribing or for discontinuing the medication included side effects, low BMI, history of pancreatitis, patient preference to avoid injection, allergy, and cost limitations. This evidence concerns the gene GLP1R and Allergy.